semaglutide cardiovascular trial Beyond obesity: Novo's SELECT re-defines risk management In people with diabetes or

Why 4 week intervals matter The 4 week escalation interval was not chosen randomly

In the diabetes GLP-1 CV outcome trials, when the mechanism of CV risk reduction was analyzed, neither weight loss nor A1c reduction explained the benefit.

You can read the full article at Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Tirzepatide is a recently approved medication for the treatment of type 2 diabetes

How Long Can Tirzepatide Be Stored Outside the Refrigerator

Tirzepatide reaches its peak concentration in the body within 8-72 hours

Can my dose be customized based on my weight loss progress